The trajectory of Viagra, initially marketed by copyright, presents a intricate case study for investors considering the healthcare arena . Although its initial success and creation of countless in sales, the patent lapse has opened the floodgates for alternative medications, significantly diminishing earnings opportunities. This change raises doub